首页> 外文会议>2014 IEEE Central America and Panama Convention >Chloroquine effect on rotor termination under paroxysmal and chronic atrial fibrillation. 2D simulation study
【24h】

Chloroquine effect on rotor termination under paroxysmal and chronic atrial fibrillation. 2D simulation study

机译:在阵发性和慢性心房颤动下,氯喹对转子终止的作用。 2D模拟研究

获取原文
获取原文并翻译 | 示例

摘要

Atrial fibrillation (AF) is the most common prevalent cardiac arrhythmia. If the paroxysmal AF (pAF) is not treated it could become chronic AF (cAF). Blockade of inward rectifying potassium (I) and acetylcholine-activated potassium (I) currents by the antimalarial drug chloroquine could play a role as antiarrhythmic drug in human AF. We simulated the effects of chloroquine on human atrial tissue to study its effect on rotor termination, under pAF and cAF conditions. For this, we modified a human cell model to obtain pAF and cAF models and we developed a model of chloroquine effects on I and I Rotors were generated in a 2D model of atrial tissue and different chloroquine concentrations were applied. Our results show that chloroquine blocks both currents, which results in action potential duration (APD) lengthening. Chloroquine has a greater effect on pAF conditions and high chloroquine concentration is needed to achieve similar effects in cAF. In pAF, was necessary 0.3 μM or more, in order to terminate the rotor, however, in cAF, was necessary a higher chloroquine concentration (0.5 μM). Our results suggest that the antimalarial drug chloroquine could be a potent antiarrhythmic agent in the treatment of pAF at concentrations from 0.3 μM and in the treatment of cAF at higher concentrations, from 0.5 μM.
机译:心房颤动(AF)是最常见的普遍性心律不齐。如果不治疗阵发性房颤(pAF),可能会变成慢性房颤(cAF)。抗疟药氯喹对内向整流钾(I)和乙酰胆碱激活的钾(I)电流的阻断可能在人房颤中起抗心律失常药的作用。我们模拟了氯喹对人心房组织的影响,以研究其在pAF和cAF条件下对转子终止的影响。为此,我们修改了人类细胞模型以获得pAF和cAF模型,并建立了氯喹对I和I效应的模型。在心房组织的二维模型中生成了转子,并应用了不同的氯喹浓度。我们的结果表明,氯喹阻断了两种电流,这导致动作电位持续时间(APD)延长。氯喹对pAF条件有更大的影响,需要高浓度的氯喹才能在cAF中达到类似的效果。在pAF中,为了终止转子,必须为0.3μM或更高,但是在cAF中,则需要更高的氯喹浓度(0.5μM)。我们的结果表明,抗疟药氯喹在浓度为0.3μM的pAF的治疗中和在浓度为0.5μM的更高浓度的cAF的治疗中可能是一种有效的抗心律不齐药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号